Report Detail

Pharma & Healthcare COVID-19 Impact on Global Non-steroidal Anti-inflammatory Drugs(NSAID), Market Insights and Forecast to 2026

  • RnM4084618
  • |
  • 30 June, 2020
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Study Coverage

  • 1.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Non-steroidal Anti-inflammatory Drugs(NSAID) Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Growth Rate by Type
    • 1.4.2 Aspirin
    • 1.4.3 Ibuprofen
    • 1.4.4 Naproxen
    • 1.4.5 Nabumetone
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Growth Rate by Application
    • 1.5.2 Back Pain Treatment
    • 1.5.3 Osteoarthritis Treatment
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Non-steroidal Anti-inflammatory Drugs(NSAID) Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Non-steroidal Anti-inflammatory Drugs(NSAID) Industry
      • 1.6.1.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Non-steroidal Anti-inflammatory Drugs(NSAID) Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Non-steroidal Anti-inflammatory Drugs(NSAID) Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Estimates and Forecasts
    • 2.1.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue 2015-2026
    • 2.1.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales 2015-2026
  • 2.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Competitor Landscape by Players

  • 3.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Manufacturers
    • 3.1.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Manufacturers (2015-2020)
    • 3.1.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Manufacturers
    • 3.2.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Manufacturers (2015-2020)
    • 3.2.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue in 2019
    • 3.2.5 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Non-steroidal Anti-inflammatory Drugs(NSAID) Price by Manufacturers
  • 3.4 Non-steroidal Anti-inflammatory Drugs(NSAID) Manufacturing Base Distribution, Product Types
    • 3.4.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Non-steroidal Anti-inflammatory Drugs(NSAID) Product Type
    • 3.4.3 Date of International Manufacturers Enter into Non-steroidal Anti-inflammatory Drugs(NSAID) Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size by Type (2015-2020)
    • 4.1.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Type (2015-2020)
    • 4.1.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Type (2015-2020)
    • 4.1.3 Non-steroidal Anti-inflammatory Drugs(NSAID) Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast by Type (2021-2026)
    • 4.2.3 Non-steroidal Anti-inflammatory Drugs(NSAID) Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size by Application (2015-2020)
    • 5.1.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Application (2015-2020)
    • 5.1.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Application (2015-2020)
    • 5.1.3 Non-steroidal Anti-inflammatory Drugs(NSAID) Price by Application (2015-2020)
  • 5.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Non-steroidal Anti-inflammatory Drugs(NSAID) by Country
    • 6.1.1 North America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Country
    • 6.1.2 North America Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Type
  • 6.3 North America Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) by Country
    • 7.1.1 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Country
    • 7.1.2 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Type
  • 7.3 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) by Region
    • 8.1.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Region
    • 8.1.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Type
  • 8.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Non-steroidal Anti-inflammatory Drugs(NSAID) by Country
    • 9.1.1 Latin America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Country
    • 9.1.2 Latin America Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Type
  • 9.3 Central & South America Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) by Country
    • 10.1.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Country
    • 10.1.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Type
  • 10.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Bayer
    • 11.1.1 Bayer Corporation Information
    • 11.1.2 Bayer Description, Business Overview and Total Revenue
    • 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
    • 11.1.5 Bayer Recent Development
  • 11.2 Novacap
    • 11.2.1 Novacap Corporation Information
    • 11.2.2 Novacap Description, Business Overview and Total Revenue
    • 11.2.3 Novacap Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novacap Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
    • 11.2.5 Novacap Recent Development
  • 11.3 Abbott
    • 11.3.1 Abbott Corporation Information
    • 11.3.2 Abbott Description, Business Overview and Total Revenue
    • 11.3.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Abbott Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
    • 11.3.5 Abbott Recent Development
  • 11.4 Pfizer
    • 11.4.1 Pfizer Corporation Information
    • 11.4.2 Pfizer Description, Business Overview and Total Revenue
    • 11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Pfizer Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
    • 11.4.5 Pfizer Recent Development
  • 11.5 Geri-Care Pharmaceuticals
    • 11.5.1 Geri-Care Pharmaceuticals Corporation Information
    • 11.5.2 Geri-Care Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.5.3 Geri-Care Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
    • 11.5.5 Geri-Care Pharmaceuticals Recent Development
  • 11.6 Perrigo Company
    • 11.6.1 Perrigo Company Corporation Information
    • 11.6.2 Perrigo Company Description, Business Overview and Total Revenue
    • 11.6.3 Perrigo Company Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Perrigo Company Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
    • 11.6.5 Perrigo Company Recent Development
  • 11.7 Kopran
    • 11.7.1 Kopran Corporation Information
    • 11.7.2 Kopran Description, Business Overview and Total Revenue
    • 11.7.3 Kopran Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Kopran Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
    • 11.7.5 Kopran Recent Development
  • 11.8 Merck Sharp & Dohme
    • 11.8.1 Merck Sharp & Dohme Corporation Information
    • 11.8.2 Merck Sharp & Dohme Description, Business Overview and Total Revenue
    • 11.8.3 Merck Sharp & Dohme Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
    • 11.8.5 Merck Sharp & Dohme Recent Development
  • 11.9 Sun Pharmaceutical Industries
    • 11.9.1 Sun Pharmaceutical Industries Corporation Information
    • 11.9.2 Sun Pharmaceutical Industries Description, Business Overview and Total Revenue
    • 11.9.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
    • 11.9.5 Sun Pharmaceutical Industries Recent Development
  • 11.10 Glaxo Smith Kline
    • 11.10.1 Glaxo Smith Kline Corporation Information
    • 11.10.2 Glaxo Smith Kline Description, Business Overview and Total Revenue
    • 11.10.3 Glaxo Smith Kline Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
    • 11.10.5 Glaxo Smith Kline Recent Development
  • 11.1 Bayer
    • 11.1.1 Bayer Corporation Information
    • 11.1.2 Bayer Description, Business Overview and Total Revenue
    • 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
    • 11.1.5 Bayer Recent Development
  • 11.12 Johnson & Johnson
    • 11.12.1 Johnson & Johnson Corporation Information
    • 11.12.2 Johnson & Johnson Description, Business Overview and Total Revenue
    • 11.12.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Johnson & Johnson Products Offered
    • 11.12.5 Johnson & Johnson Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Market Estimates and Projections by Region
    • 12.1.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast by Regions 2021-2026
  • 12.2 North America Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast (2021-2026)
    • 12.2.1 North America: Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast (2021-2026)
    • 12.2.2 North America: Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast (2021-2026)
    • 12.2.3 North America: Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast (2021-2026)
    • 12.3.2 Europe: Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Non-steroidal Anti-inflammatory Drugs(NSAID) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Non-steroidal Anti-inflammatory Drugs(NSAID) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-steroidal Anti-inflammatory Drugs(NSAID) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Non-steroidal Anti-inflammatory Drugs(NSAID) market is segmented into
    Aspirin
    Ibuprofen
    Naproxen
    Nabumetone
    Others

    Segment by Application, the Non-steroidal Anti-inflammatory Drugs(NSAID) market is segmented into
    Back Pain Treatment
    Osteoarthritis Treatment
    Others

    Regional and Country-level Analysis
    The Non-steroidal Anti-inflammatory Drugs(NSAID) market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Non-steroidal Anti-inflammatory Drugs(NSAID) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Non-steroidal Anti-inflammatory Drugs(NSAID) Market Share Analysis
    Non-steroidal Anti-inflammatory Drugs(NSAID) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Non-steroidal Anti-inflammatory Drugs(NSAID) business, the date to enter into the Non-steroidal Anti-inflammatory Drugs(NSAID) market, Non-steroidal Anti-inflammatory Drugs(NSAID) product introduction, recent developments, etc.
    The major vendors covered:
    Bayer
    Novacap
    Abbott
    Pfizer
    Geri-Care Pharmaceuticals
    Perrigo Company
    Kopran
    Merck Sharp & Dohme
    Sun Pharmaceutical Industries
    Glaxo Smith Kline
    Reddy Pharmaceuticals
    Johnson & Johnson


    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Non-steroidal Anti-inflammatory Drugs(NSAID). Industry analysis & Market Report on COVID-19 Impact on Global Non-steroidal Anti-inflammatory Drugs(NSAID) is a syndicated market report, published as COVID-19 Impact on Global Non-steroidal Anti-inflammatory Drugs(NSAID), Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Non-steroidal Anti-inflammatory Drugs(NSAID) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,093.32
    4,639.99
    6,186.65
    3,453.84
    5,180.76
    6,907.68
    416,882.70
    625,324.05
    833,765.40
    293,247.24
    439,870.86
    586,494.48
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report